Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Preparation and Approval of Working Standards – V 2.0

Posted on By

Analytical Method Development: SOP for Preparation and Approval of Working Standards – V 2.0

Standard Operating Procedure for Preparation and Approval of Working Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/342/2025
Supersedes SOP/AMD/342/2022
Page No. Page 1 of 11
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to establish a detailed procedure for the preparation, qualification, and approval of working standards used in analytical method development and routine

testing activities within the laboratory.

2. Scope

This SOP is applicable to all working standards derived from certified reference standards, pharmacopeial standards, or in-house standards for use in quality control or analytical method development.

3. Responsibilities

  • Analytical Chemist: Prepares, labels, and submits working standard samples for analysis.
  • QA Reviewer: Reviews documentation and approves the working standard based on predefined acceptance criteria.
  • Documentation Officer: Maintains logs, COA copies, and calibration data for all approved working standards.
See also  Analytical Method Development: SOP for Oxidative Degradation Study Method - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the proper implementation of this SOP and ensuring compliance with applicable regulatory and quality requirements for reference material handling.

5. Procedure

5.1 Procurement and Receipt of Reference Standard

  1. Obtain pharmacopeial reference standards (USP, BP, EP, IP) or certified in-house reference standards.
  2. Verify COA and expiration date upon receipt.
  3. Record batch number, potency, and expiry date in Reference Standard Receipt Log (Annexure-1).

5.2 Preparation of Working Standard

  1. Weigh appropriate quantity of reference standard in a clean and dry container using calibrated balance.
  2. Mix and homogenize thoroughly to ensure consistency.
  3. Store the working standard in airtight, labeled amber bottles.
  4. Label must include:
    • Material name
    • Batch number
    • Prepared by and date
    • Potency and storage conditions

5.3 Characterization and Qualification

  1. Determine the following parameters:
    • Identity by IR or UV
    • Assay by validated method (minimum 3 replicates)
    • Moisture content by KF titration
    • Any additional tests as per product-specific requirement
  2. Calculate potency using assay value and LOD correction, where applicable.
  3. Enter results in Working Standard Qualification Sheet (Annexure-2).
See also  Analytical Method Development: Complexometric Titration Method Development - V 2.0

5.4 Approval and Release

  1. Submit the qualification sheet and COA to QA for review and approval.
  2. On approval, assign working standard ID and enter in Working Standard Register (Annexure-3).
  3. Distribute small aliquots to analysts with usage log and instructions for handling.

5.5 Re-Qualification and Expiry Monitoring

  1. Working standards should be re-qualified every 6 months or based on usage pattern.
  2. Record re-qualification data in Annexure-2 under new entry date.
  3. Destroy expired standards as per SOP for disposal and update the register accordingly.

6. Abbreviations

  • COA: Certificate of Analysis
  • LOD: Loss on Drying
  • KF: Karl Fischer
  • USP: United States Pharmacopeia
  • IR: Infrared Spectroscopy

7. Documents

  1. Annexure-1: Reference Standard Receipt Log
  2. Annexure-2: Working Standard Qualification Sheet
  3. Annexure-3: Working Standard Register

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • USP General Chapter <11> – Reference Standards
  • WHO TRS 996 – Quality Control of Pharmaceutical Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Deepika Sharma Neeraj Thakur Dr. Rakesh Shetty
Designation Analytical Chemist QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Reference Standard Receipt Log

Date Standard Name Source Batch No. Potency Expiry Received By
28/05/2025 Paracetamol CRS USP PSM-023 99.6% 31/12/2026 D. Sharma

Annexure-2: Working Standard Qualification Sheet

Includes data on IR spectra, assay result, moisture content, calculated potency, and QA approval signature.

Annexure-3: Working Standard Register

WS ID Material Preparation Date Potency Expiry Requalified On
WS/AMD/101 Paracetamol 30/05/2025 99.4% 30/11/2025 —

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Updated requalification interval and moisture analysis requirement Annual SOP review Dr. Rakesh Shetty
10/08/2022 1.0 Initial release New SOP QA Head
See also  Analytical Method Development: Total Viable Count Method Optimization - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Reporting QC Out-of-Specification Results – V 2.0
Next Post: Elixir Department: SOP for Sample Retention Procedure – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version